Beta Bionics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Beta Bionics, Inc. (BBNX) on March 26, 2025. The filing reports a corporate governance event regarding the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and compensation matters rather than financial performance.
Material Changes
The primary material change reported is the appointment of Gerard Michelas as a Class III director, effective March 26, 2025. His term expires at the 2028 annual meeting of stockholders. No other material changes to operations or financial status are disclosed in this document.
Management Commentary and Compensation Details
Mr. Michelas was appointed upon the recommendation of the Nominating and Corporate Governance Committee. His background includes serving as CEO and director at Delcath Systems, Inc., and previously as CFO at Vericel Corporation, Biodel, Inc., and NPS Pharmaceuticals Inc.
Compensatory arrangements for Mr. Michelas include:
- Annual Cash Retainer: $50,000 for service on the Board.
- Initial Equity Grant: 12,547 restricted stock units (RSUs) granted on the date of appointment, vesting in full on the one-year anniversary.
- Future Equity Grants: Automatic grants of RSUs with an aggregate grant date value of $165,000 on the date of each annual meeting of stockholders.
- Vesting Conditions: All grants vest in full upon a change in control. Standard service conditions apply otherwise.
Mr. Michelas has also entered into the Company's standard form of Indemnification Agreement.
Investor Verification Checklist
- Verify the total number of authorized shares and the impact of the 12,547 RSU grant on potential dilution.
- Review the Company's 2025 Equity Incentive Plan to confirm the availability of shares for future automatic grants.
- Confirm the specific vesting schedule and any performance conditions attached to the RSUs beyond continuous service.
- Check for any related party transactions or conflicts of interest involving Mr. Michelas not disclosed in this filing.